# Assessment: AUC=0.72 and Brier=0.19 for Clinical Trial Use

**AUC=0.72** falls in the lower-moderate range (acceptable = 0.70–0.80). It means the model correctly ranks a positive case above a negative case 72% of the time — leaving substantial discrimination errors.

**Brier=0.19** needs context. At 20% outcome prevalence, the null (prevalence-only) model scores ~0.16, so 0.19 is actually *worse* than guessing the base rate. At 30% prevalence the null is ~0.21, making 0.19 a slight improvement. The model's calibration is marginal at best.

**Verdict: Generally not sufficient for primary clinical trial decision-making.** Typical standards:
- Enrichment/patient selection: AUC >= 0.75–0.80
- Adaptive randomization: requires tight calibration (Brier well below null model)
- Exploratory stratification only: borderline acceptable with caveats

Recommendations: improve the model (feature engineering, calibration methods), conduct external validation, clarify the exact role in the trial, and consult a biostatistician before proceeding.
